JP2015532425A - 粘膜治癒を予測及びモニタリングするための方法 - Google Patents

粘膜治癒を予測及びモニタリングするための方法 Download PDF

Info

Publication number
JP2015532425A
JP2015532425A JP2015535153A JP2015535153A JP2015532425A JP 2015532425 A JP2015532425 A JP 2015532425A JP 2015535153 A JP2015535153 A JP 2015535153A JP 2015535153 A JP2015535153 A JP 2015535153A JP 2015532425 A JP2015532425 A JP 2015532425A
Authority
JP
Japan
Prior art keywords
asca
tnfα
hgf
ereg
egf
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015535153A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015532425A5 (cg-RX-API-DMAC10.html
Inventor
シャラト シング，
シャラト シング，
シン‐ジュン リウ，
シン‐ジュン リウ，
スコット ハウエンシュタイン，
スコット ハウエンシュタイン，
リチャード カークランド，
リチャード カークランド，
キャサリン ドレイク，
キャサリン ドレイク，
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nestec SA
Original Assignee
Nestec SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec SA filed Critical Nestec SA
Publication of JP2015532425A publication Critical patent/JP2015532425A/ja
Publication of JP2015532425A5 publication Critical patent/JP2015532425A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/06—Gastro-intestinal diseases
    • G01N2800/065—Bowel diseases, e.g. Crohn, ulcerative colitis, IBS
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Databases & Information Systems (AREA)
  • Data Mining & Analysis (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2015535153A 2012-10-05 2013-10-02 粘膜治癒を予測及びモニタリングするための方法 Pending JP2015532425A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261710491P 2012-10-05 2012-10-05
US61/710,491 2012-10-05
US201361824959P 2013-05-17 2013-05-17
US61/824,959 2013-05-17
PCT/IB2013/059077 WO2014054013A1 (en) 2012-10-05 2013-10-02 Methods for predicting and monitoring mucosal healing

Publications (2)

Publication Number Publication Date
JP2015532425A true JP2015532425A (ja) 2015-11-09
JP2015532425A5 JP2015532425A5 (cg-RX-API-DMAC10.html) 2016-11-24

Family

ID=49447587

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015535153A Pending JP2015532425A (ja) 2012-10-05 2013-10-02 粘膜治癒を予測及びモニタリングするための方法

Country Status (11)

Country Link
US (1) US20150355195A1 (cg-RX-API-DMAC10.html)
EP (3) EP3640645A1 (cg-RX-API-DMAC10.html)
JP (1) JP2015532425A (cg-RX-API-DMAC10.html)
CN (1) CN104838270A (cg-RX-API-DMAC10.html)
AU (2) AU2013326070A1 (cg-RX-API-DMAC10.html)
CA (1) CA2887035A1 (cg-RX-API-DMAC10.html)
ES (2) ES2638971T3 (cg-RX-API-DMAC10.html)
HK (1) HK1213051A1 (cg-RX-API-DMAC10.html)
MX (1) MX358730B (cg-RX-API-DMAC10.html)
SG (1) SG11201502646RA (cg-RX-API-DMAC10.html)
WO (1) WO2014054013A1 (cg-RX-API-DMAC10.html)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020523560A (ja) * 2017-05-31 2020-08-06 プロメテウス バイオサイエンシーズ インコーポレイテッド クローン病患者の粘膜治癒を評価する方法
JP2020198884A (ja) * 2016-07-05 2020-12-17 ケンブリッジ エンタープライズ リミテッド 炎症性腸疾患用のバイオマーカー

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3295783A1 (en) 2011-05-10 2026-03-02 Prometheus Laboratories, Inc. Methods of disease activity profiling for personalized therapy management
WO2016063223A1 (en) * 2014-10-20 2016-04-28 Nestec S.A. Methods for predicting clinical outcomes in subjects afflicted with ulcerative colitis
US20170258820A1 (en) 2014-10-29 2017-09-14 Glycom A/S Synthetic composition and method for promoting mucosal healing
GB201501612D0 (en) * 2015-01-30 2015-03-18 Univ Birmingham Assay
CN109462996A (zh) 2016-03-17 2019-03-12 西达-赛奈医疗中心 通过rnaset2诊断炎性肠病的方法
WO2020112890A1 (en) 2018-11-29 2020-06-04 Cedars-Sinai Medical Center Rnaset2 compositions and methods of treatment therewith
CN110646620A (zh) * 2019-09-29 2020-01-03 湖北新纵科病毒疾病工程技术有限公司 一种同时检测四项炎症标志物的方法及其试剂盒
CN111477325A (zh) * 2020-04-09 2020-07-31 赣南师范大学 基于粒子群优化算法对引发肠道溃疡疾病进行鉴别的方法
CN120600283B (zh) * 2025-05-29 2026-02-17 北京大学第三医院（北京大学第三临床医学院） 一种基于临床知识图谱的中医生殖内分泌疾病诊断辅助系统

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006521537A (ja) * 2003-04-01 2006-09-21 ザ プロクター アンド ギャンブル カンパニー 腸の炎症性疾患の治療の有効性を決定する方法
WO2011066458A2 (en) * 2009-11-25 2011-06-03 Prometheus Laboratories Inc. Novel genomic biomarkers for irritable bowel syndrome diagnosis
WO2011153501A2 (en) * 2010-06-04 2011-12-08 Prometheus Laboratories Inc. Methods for improving inflammatory bowel disease diagnosis

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830675A (en) 1993-03-10 1998-11-03 Cedars-Sinai Medical Center Methods for selectively detecting perinuclear anti-neutrophil cytoplasmic antibody of ulcerative colitis, primary sclerosing cholangitis, or type 1 autoimmune hepatitis
EP0615129B1 (en) 1993-03-10 2000-05-31 Cedars-Sinai Medical Center Methods for selectively detecting perinuclear anti-neutrophil cytoplasmic antibody of ulcerative colitis or primary sclerosing cholangitis
US6218129B1 (en) 1998-05-15 2001-04-17 Prometheus Laboratories, Inc. Inflammatory bowel disease first step assay system
US6406862B1 (en) 1998-10-06 2002-06-18 The United States Of America As Represented By The Secretary Of The Army Dip-stick assay for C-reactive protein
FR2802536B1 (fr) 1999-11-23 2003-06-13 Chru Lille Oligomannosides de synthese, leur preparation et leur utilisation a la detection d'anticorps et a la prevention d'infections
US6838250B2 (en) 2000-03-31 2005-01-04 Ortho-Clinical Diagnostics, Inc. Immunoassay for C-reactive protein
AU2001253746A1 (en) * 2000-04-20 2001-11-07 The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Inducible plasmid vector encoding tgf-beta and uses thereof
US7138237B1 (en) 2000-05-19 2006-11-21 Cedars-Sinai Medical Center Diagnosis, prevention and treatment of Crohn's disease using the OmpC antigen
EP1581119B1 (en) 2001-12-17 2013-01-30 Corixa Corporation Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
CA2549971A1 (en) 2003-11-03 2005-05-12 Duke University Methods of identifying individuals at risk of perioperative bleeding, renal dysfunction or stroke
WO2006012472A1 (en) 2004-07-21 2006-02-02 Qualyst, Inc. Apparatus, kits and methods for evaluating binding interactions, for detecting and quantifying binding molecules, and for sample preparation
WO2007087576A2 (en) 2006-01-24 2007-08-02 The Uab Research Foundation Compositions and methods for the identification and treatment of immune-mediated inflammatory diseases
CN104198705B (zh) 2006-09-21 2017-06-09 雀巢产品技术援助有限公司 检测稀有循环细胞内多种信号转导分子的基于抗体的阵列
NZ582618A (en) 2007-07-13 2012-07-27 Prometheus Lab Inc Drug selection for lung cancer therapy using antibody-based arrays
ES2553390T3 (es) 2008-02-25 2015-12-09 Nestec S.A. Método para la detección de receptores truncados intracelulares
CN101780269A (zh) * 2009-01-21 2010-07-21 北京三有利科技发展有限公司 细胞生长因子治疗溃疡性疾病和肺纤维化疾病的应用
NZ596468A (en) 2009-05-14 2013-11-29 Nestec Sa Biomarkers for determining sensitivity of breast cancer cells to her2-targeted therapy
JP5795311B2 (ja) 2009-07-15 2015-10-14 ネステク ソシエテ アノニム 抗体ベースのアレイを使用する胃癌療法のための薬物選択
DK2491385T3 (en) 2009-10-20 2017-08-28 Diatech Holdings Inc PROXIMITY-MEDIED ASSAYS FOR DETECTING ONCOGEN FUSION PROTEINS
CN104634955B (zh) 2009-10-26 2016-09-14 雀巢产品技术援助有限公司 检测抗-tnf药物和自身抗体的试验
WO2012054532A1 (en) 2010-10-18 2012-04-26 Prometheus Laboratories Inc. Methods for determining anti-drug antibody isotypes
SG191230A1 (en) 2010-12-23 2013-07-31 Nestec Sa Drug selection for malignant cancer therapy using antibody-based arrays
MX343327B (es) 2011-02-17 2016-11-01 Nestec Sa Ensayos para detectar autoanticuerpos contra farmacos anti-tnfa.
EP2681552A2 (en) 2011-03-02 2014-01-08 Nestec S.A. Prediction of drug sensitivity of lung tumors based on molecular and genetic signatures
WO2013006810A1 (en) 2011-07-06 2013-01-10 Nestec Sa Assays for detecting neutralizing autoantibodies to biologic therapy with tnf alpha
KR101851425B1 (ko) 2011-09-02 2018-04-23 네스텍 소시에테아노님 치료 효능 결정을 위한 신호 경로 단백질의 프로파일링

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006521537A (ja) * 2003-04-01 2006-09-21 ザ プロクター アンド ギャンブル カンパニー 腸の炎症性疾患の治療の有効性を決定する方法
WO2011066458A2 (en) * 2009-11-25 2011-06-03 Prometheus Laboratories Inc. Novel genomic biomarkers for irritable bowel syndrome diagnosis
WO2011153501A2 (en) * 2010-06-04 2011-12-08 Prometheus Laboratories Inc. Methods for improving inflammatory bowel disease diagnosis

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
GEBOES K ET AL.: "Endoscopic and histologic evidence of persistent mucosal healing and correlation with clinical impro", CURR MED RES OPIN., vol. 21, no. 11, JPN6017032788, 2005, pages 1741 - 1754, ISSN: 0003629825 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020198884A (ja) * 2016-07-05 2020-12-17 ケンブリッジ エンタープライズ リミテッド 炎症性腸疾患用のバイオマーカー
JP7111630B2 (ja) 2016-07-05 2022-08-02 ケンブリッジ エンタープライズ リミテッド 炎症性腸疾患用のバイオマーカー
JP2020523560A (ja) * 2017-05-31 2020-08-06 プロメテウス バイオサイエンシーズ インコーポレイテッド クローン病患者の粘膜治癒を評価する方法

Also Published As

Publication number Publication date
AU2019204276A1 (en) 2019-07-04
CA2887035A1 (en) 2014-04-10
ES2771127T3 (es) 2020-07-06
MX2015004272A (es) 2015-08-14
CN104838270A (zh) 2015-08-12
AU2013326070A1 (en) 2015-04-23
EP3217179A1 (en) 2017-09-13
ES2638971T3 (es) 2017-10-24
SG11201502646RA (en) 2015-05-28
EP3217179B1 (en) 2020-01-08
EP2904405B1 (en) 2017-05-31
EP3217179B9 (en) 2020-06-10
EP3640645A1 (en) 2020-04-22
MX358730B (es) 2018-09-03
WO2014054013A1 (en) 2014-04-10
US20150355195A1 (en) 2015-12-10
EP2904405A1 (en) 2015-08-12
HK1213051A1 (zh) 2016-06-24

Similar Documents

Publication Publication Date Title
EP3217179B1 (en) Methods for predicting and monitoring mucosal healing
US12485171B2 (en) Methods of disease activity profiling for personalized therapy management
CN103299190B (zh) 确定抗药物抗体同种型的方法
CN103782172A (zh) 检测针对使用TNFα的生物疗法的中和性自体抗体的测定法
EP3077818B1 (en) Methods for predicting post-operative recurrence of crohn's disease
JP2013528389A (ja) 炎症性腸疾患の診断を改善させる方法
WO2015166461A1 (en) Methods of selecting treatment regimen using tnf alpha and anti-tnf alpha drug levels
HK40017436A (en) Methods of disease activity profiling for personalized therapy management
RU2574976C2 (ru) Способы определения изотипа антител против лекарственных препаратов

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160930

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20160930

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20170705

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20170905

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20171205

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20180327